| Trial ID: | L2924 |
| Source ID: | NCT00123604
|
| Associated Drug: |
Carvedilol
|
| Title: |
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00123604/results
|
| Conditions: |
Hypertension|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Carvedilol|DRUG: Metoprolol
|
| Outcome Measures: |
Primary: Flow Mediated Dilation, Flow mediated dilation is a measure of endothelial function. It is measured by the percent change in artery diameter (i.e. dilation), pre and post manual artery occlusion., change from baseline to 5 months |
|
| Sponsor/Collaborators: |
Sponsor: St. Paul Heart Clinic | Collaborators: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2004-06
|
| Completion Date: |
2006-06
|
| Results First Posted: |
2014-11-18
|
| Last Update Posted: |
2014-11-18
|
| Locations: |
St. Paul Heart Clinic, St. Paul, Minnesota, 55102, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00123604
|
